Project Report for Infusion Pump
It takes more than a boilerplate write-up for the bank to establish manufacturing, trade, or a healthcare facility around an infusion pump. For an infusion pump company, this page provides actual equipment cost, CDSCO classification, and financing options so that your report will stand up when a loan officer really evaluates it. Sharda Associates creates your infusion pump project report with the precise machine cost and CDSCO Class C compliance status. Get a Completely Custom Bankable Project Report—Rs. 2,999 onwards, delivered in 24-48 hrs, backed by 45,500+ CA-certified reports accepted by SBI, PNB, Bank of Baroda, and all scheduled banks.
Get free Sample
What is an infusion pump?
An infusion pump is a medical device that administers fluids—like blood, nutrients, or medications—directly into a patient’s body in extremely exact and regulated volumes. An infusion pump is mechanized to provide precise dosing at a predetermined, programmed pace, in contrast to a manual intravenous (IV) drip, which depends on gravity and manual adjustments.
These devices are frequently used in clinics, hospitals, and home care settings to deliver vital fluids like insulin, antibiotics, chemotherapeutic medications, and painkillers due to their great precision.
Additionally, they have sophisticated built-in safety features that avoid dangerous drug errors and guarantee patient safety, such as sensors that sound an alarm if there is an air bubble in the tubing, a fluid blockage (occlusion), or a low battery.
Types and Price Range in India
Pump Type | Typical Price Range (₹) | Common Use |
Syringe pump | 12,000 – 2,00,000 | Precise small-volume delivery (ICU, NICU, hormones) |
Volumetric infusion pump | 25,000 – 1,80,000 | Continuous large-volume delivery (nutrition, saline) |
Ambulatory/portable pump | 40,000 – 1,50,000 | Home care, chemotherapy, mobile patients |
Enteral feeding pump | 56,000 – 1,15,000 | Tube feeding, nutrition support |
PCA (patient-controlled analgesia) pump | 1,34,500 – 3,22,500 | Pain management, post-surgical care |
Brands commonly financed by banks include B. Braun, BPL, Smiths Medical, Fresenius Kabi, Mindray, and Comen (new or CDSCO-cleared refurbished units).
Regulatory Status You Must Address
Under CDSCO’s Medical Device Rules, 2017, an infusion pump is classified as a Class C (moderate-to-high risk) device, in the same bracket as X-ray machines and ventilators. This means:
- A manufacturing/import license through the Central Licensing Authority is mandatory before you can legally sell or operate the equipment commercially
- State Licensing Authority clearance is not enough for Class C, since it routes through CDSCO’s central portal
- Trading/distribution units need proper CDSCO-registered supplier invoices to satisfy bank due diligence on an infusion-pump purchase
We flag exactly which approvals your case needs before the file goes to the bank, so it isn’t returned for a missing license.
Financing Routes That Fit This Business
- Mudra loan (Shishu/Kishor/Tarun): collateral-free, up to ₹10 lakh for first-time borrowers; the Tarun Plus category extends this to ₹20 lakh for entrepreneurs who’ve already repaid a prior Tarun loan
- PMEGP: for a manufacturing or trading unit around infusion pump supply, project cost cap is ₹50 lakh (manufacturing) or ₹20 lakh (services/trading), with 15-35% margin money subsidy depending on category and location
- CGTMSE-backed MSME term loan: for higher project costs, collateral-free coverage up to the eligible limit for equipment purchase and working capital
Frequently Asked Questions
An infusion pump manufacturing project report is a detailed document that explains the technical, financial, and commercial feasibility of setting up an infusion pump production unit. It typically includes investment estimates, machinery, raw materials, manufacturing process, projected financial statements, and market analysis.
Banks use the project report to evaluate the business's viability before approving a loan. It helps them assess project cost, expected revenue, profitability, cash flow, repayment capacity, and overall business feasibility.
A comprehensive report generally includes market analysis, manufacturing process, machinery details, raw materials, land and infrastructure requirements, licenses, manpower planning, project cost, working capital, projected financial statements, DSCR, break-even analysis, and profitability projections.
Manufacturers may require business registration, GST registration, Factory License (where applicable), and approvals under the Medical Devices Rules, 2017, administered by the Central Drugs Standard Control Organization (CDSCO), along with other applicable state or local approvals depending on the manufacturing activity.
Sometimes, but many banks and government schemes have different documentation requirements. The project report should be customized according to the lender's or scheme's guidelines for better acceptance.
The investment depends on production capacity, automation, machinery, cleanroom requirements, testing equipment, and factory infrastructure. A detailed project report helps estimate the approximate project cost based on your business plan.
Many banks and financial institutions prefer or require a CA-certified project report because it improves the credibility of the financial projections. The exact requirement depends on the lender and loan scheme.
Yes. A customized report can be prepared based on your proposed production capacity, machinery selection, investment budget, funding requirements, and target market, making it more relevant for bank financing or investor discussions.
The preparation time depends on the complexity of the project and the information provided by the entrepreneur. Customized reports generally take longer than standard formats because they require project-specific financial and technical analysis.
Sharda Associates prepares CA-certified, bankable project reports tailored to your business requirements. The reports are designed for bank loans, MSME financing, and investor presentations, with detailed financial projections, technical feasibility, and documentation support.